Completed PHASE3 INTERVENTIONAL 2-arm NCT00150969

Vitamin K Supplementation in Post-Menopausal Osteopenia

Evaluation of the Clinical Use of Vitamin K Supplementation in Post-Menopausal Women With Osteopenia (ECKO Trial)

Sponsor: Canadian Institutes of Health Research (CIHR)

Conditions Post-Menopausal Osteopenia Post-Menopausal Osteoporosis

Interventions placebo vitamin K1 (phylloquinone)

Updated 7 times since 2017 Last updated: Dec 4, 2023 Started: Jan 31, 2002 Primary completion: Sep 30, 2006 Completion: Sep 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Post-Menopausal Osteopenia and Post-Menopausal Osteoporosis and is currently completed. Canadian Institutes of Health Research (CIHR) leads this study, which shows 7 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2024 — Jul 2024 [monthly]

Completed PHASE3
Dec 2021 — Jan 2024 [monthly]

Completed PHASE3
Jan 2021 — Dec 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canadian Institutes of Health Research (CIHR)
University Health Network, Toronto

Data source: University Health Network, Toronto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada